Dr. Michael Farzan: ACE2, the SARS-CoV-2 S protein, and better RBD-based vaccines

Published 2020-08-28

Download video MP4 360p

Recommendations

Similar videos

59:35

3-11-21 - Impact of SARS-CoV-2 spike protein variation on therapeutics and vaccines
04:19

Vaccine targeting the RBD of S protein of SARS-COV-2 induces protective immunity
56:40

Dr. James E. Crowe, Jr: Human Monoclonal Antibodies for SARS-CoV-2
1:09:33

Addressing the Coronavirus Challenge: Front Row Lecture with Michael Farzan, PhD
01:54

In vitro and in vivo characterization of novel SARS-CoV-2 protein subunit vaccine
59:29

Dr. Penny Moore: SARS-CoV-2 Infection and Vaccination in South Africa
1:01:02

Science of COVID-19: “Protein interaction map of SARS-CoV-2, with implications for drug targets."
59:58

Dr. Menno van Zelm: B cell memory to SARS-CoV2 Nucleocapsid and Spike proteins in COVID-19 disease
59:42

Dr. Dan Barouch: COVID-19 Vaccine Development
26:03

Will SARS Cov-2 Become Resistant to Current Vaccines - Implications | Penny Moore, PhD
05:30

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic...
1:06:27

Dr. Bette Korber: Spike mutations and recombination in SARS-CoV-2 pandemic viruses
32:13

Scripps Researcher Discusses Development of New Vaccine
1:00:26

Dr. Jesse Bloom: Interpreting the Evolution of SARS-CoV-2 in Context of Omicron
1:02:25

Prof. Shane Crotty: T cell responses to SARS-CoV-2
20:51

COVID-19 Uptake is Enhanced by NRP-1
1:00:32

Dr. Carl Dieffenbach: Vaccines for HIV, SARS-CoV-2: How Can We Build Upon Successes and Failures?
1:04:29

Dr. Barney S. Graham: Rapid COVID-19 Vaccine Development Enabled by Prototype Pathogen Preparedness
1:25:14

Science of COVID-19: “Detecting, dissecting, and disabling the SARS-CoV-2 spike.”
More results